Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science
Cardiovascular disease is the number one cause of death and disability worldwide. While substantial gains have been made in reducing cardiovascular mortality, future projections suggest that we have reached a nadir and may be at an inflection point, given the rising tide of obesity and diabetes. Eva...
Guardado en:
Autores principales: | Charles Amir German, Michael David Shapiro |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c5c0257f13f7446b997641574a3cd497 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
por: Anne Mirjam Kerola, et al.
Publicado: (2021) -
Electronic Cigarettes and Cardiovascular Risk: Science, Policy and the Cost of Certainty
por: Olusola A Orimoloye, et al.
Publicado: (2019) -
Pathways by Which Food Insecurity Is Associated With Atherosclerotic Cardiovascular Disease Risk
por: Deepak Palakshappa, et al.
Publicado: (2021) -
Inflammation and Cardiovascular Disease: The Future
por: Natalie Arnold, et al.
Publicado: (2021) -
Cardiovascular Medical Education During the Coronavirus Disease 2019 Pandemic: Challenges, Adaptations, and Considerations for the Future
por: Hilary Shapiro, et al.
Publicado: (2021)